3-(2,2,2-trimethylhydrazine)propionate and Atherosclerosis

3-(2,2,2-trimethylhydrazine)propionate has been researched along with Atherosclerosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dambrova, M; Grinberga, S; Kalvins, I; Konrade, I; Liepins, E; Petrovska, R; Pugovics, O; Skapare-Makarova, E; Tirzite, D	1
Chlopicki, S; Dambrova, M; Grinberga, S; Kalvinsh, I; Liepinsh, E; Mateuszuk, L; Vilskersts, R	1

Trials

1 trial(s) available for 3-(2,2,2-trimethylhydrazine)propionate and Atherosclerosis

Article	Year
Meldonium decreases the diet-increased plasma levels of trimethylamine N-oxide, a metabolite associated with atherosclerosis. Journal of clinical pharmacology, 2013, Volume: 53, Issue:10 Topics: Adult; Atherosclerosis; Cardiovascular Agents; Carnitine; Diet; Female; HEK293 Cells; Humans; Male; Methylamines; Methylhydrazines; Organic Cation Transport Proteins; Seafood; Solute Carrier Family 22 Member 5	2013

Article

Year

Meldonium decreases the diet-increased plasma levels of trimethylamine N-oxide, a metabolite associated with atherosclerosis.

Journal of clinical pharmacology, 2013, Volume: 53, Issue:10

Topics: Adult; Atherosclerosis; Cardiovascular Agents; Carnitine; Diet; Female; HEK293 Cells; Humans; Male; Methylamines; Methylhydrazines; Organic Cation Transport Proteins; Seafood; Solute Carrier Family 22 Member 5

2013

Other Studies

1 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and Atherosclerosis

Article	Year
Mildronate, a regulator of energy metabolism, reduces atherosclerosis in apoE/LDLR-/- mice. Pharmacology, 2009, Volume: 83, Issue:5 Topics: Animals; Aorta; Atherosclerosis; Betaine; Cardiovascular Agents; Carnitine; Energy Metabolism; Female; Lipids; Male; Methylhydrazines; Mice; Mice, Knockout; Rats; Rats, Wistar	2009